rs2302589
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004633.4(IL1R2):c.-61-191C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 152,188 control chromosomes in the GnomAD database, including 2,580 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.17   (  2580   hom.,  cov: 32) 
Consequence
 IL1R2
NM_004633.4 intron
NM_004633.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.204  
Publications
8 publications found 
Genes affected
 IL1R2  (HGNC:5994):  (interleukin 1 receptor type 2) The protein encoded by this gene is a cytokine receptor that belongs to the interleukin 1 receptor family. This protein binds interleukin alpha (IL1A), interleukin beta (IL1B), and interleukin 1 receptor, type I(IL1R1/IL1RA), and acts as a decoy receptor that inhibits the activity of its ligands. Interleukin 4 (IL4) is reported to antagonize the activity of interleukin 1 by inducing the expression and release of this cytokine. This gene and three other genes form a cytokine receptor gene cluster on chromosome 2q12. Alternative splicing results in multiple transcript variants and protein isoforms. Alternative splicing produces both membrane-bound and soluble proteins. A soluble protein is also produced by proteolytic cleavage. [provided by RefSeq, May 2012] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.31  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.167  AC: 25428AN: 152070Hom.:  2573  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
25428
AN: 
152070
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.167  AC: 25468AN: 152188Hom.:  2580  Cov.: 32 AF XY:  0.171  AC XY: 12740AN XY: 74384 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
25468
AN: 
152188
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
12740
AN XY: 
74384
show subpopulations 
African (AFR) 
 AF: 
AC: 
10548
AN: 
41514
American (AMR) 
 AF: 
AC: 
2366
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
408
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1668
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
1033
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
1816
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
41
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
7181
AN: 
68008
Other (OTH) 
 AF: 
AC: 
321
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 1084 
 2169 
 3253 
 4338 
 5422 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 278 
 556 
 834 
 1112 
 1390 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1047
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.